Objective: Vasomotor symptoms (VMS) are common during the menopausal transition. Negative affect is consistently associated with self-reported VMS, but the interpretation of this relationship is limited by the infrequent measurement and retrospective recall of VMS. Using prospective data from daily diaries, we examined the daily association between negative affect and reported VMS, as well as the temporal associations between negative affect and next-day VMS and between VMS and next-day negative affect.
H ot flashes and night sweats, also known as vasomotor symptoms (VMS), are reported by an estimated 70% to 80% of women at some point in the menopausal transition. Symptom prevalence increases with advancing menopausal stage, 1 although the duration, severity, frequency, 2 and perceived bother 3 of VMS are highly variable. Despite the common occurrence of these symptoms, the etiology underlying VMS and individual differences in symptom presentation is unclear.
The measures of negative affect seem to be among the strongest and most consistent correlates of VMS. 2, 4, 5 These associations suggest that women with more depressive symptoms, anxiety, and general negative mood are at an increased risk of reporting VMS and are more bothered by the symptoms regardless of frequency. 6 However, the interpretation of these associations is currently limited by typical measurement, in which the occurrence of VMS during the past several weeks is retrospectively self-reported along with current mood ratings. Mood at the time of reporting may bias the recall of physiological symptoms, which may inflate the association between these factors. 7 Furthermore, although typical assessments offer information about the global covariance of these symptoms, they cannot provide information on the antecedent-consequent relationship between these frequently occurring events.
Negative affect may precipitate VMS by having an impact on the subjective experience of symptoms via increased cognitive catastrophization, vigilance to somatic symptoms, or anxiety sensitivity. 8 These cognitive processes may create an environment in which the symptoms are more commonly perceived and reported. 3, 9 This relationship is supported by findings from studies using annual measurements of mood and VMS, which suggest that anxiety 10 and depressive symptoms 11<14 both precede and predict the onset of self-reported VMS in later years. It is also supported by a study of ambulatory mood and VMS assessment, in which self-reported VMS, not confirmed by physiologic evidence of VMS occurrence, was more likely to be acute emotional arousal. 7 Alternately, VMS may have a negative impact on mood. Women often report distress and embarrassment because of VMS, particularly when they occur in public. VMS may precede negative mood by activating negative schemas and triggering feelings of lack of control, embarrassment, and shame 15 or by disturbing sleep, leading to functional impairment and negative mood. 16 This relationship is supported by studies using annual measurements of mood and VMS, in which VMS in the years preceding the onset of mood symptoms predicted the development of depressive symptoms later in the menopausal transition. 17 Although both directional theories linking VMS to mood are plausible and supported largely by annually collected data, a more definitive analysis requires shorter durations between assessments. Only one study has examined the relationship between VMS and mood on a day-to-day basis. Burleson et al 18 examined 252 contiguous daily ratings from 55 healthy middle-aged women to determine whether VMS predicted next-day mood. In this sample, VMS was significantly associated with decreases in next-day positive mood but not with increases in next-day negative mood. The analysis of interactions suggested that the relationship between VMS and positive mood was seen only in individuals with low or moderate depression scores at baseline. Analyses did not examine whether mood predicted next-day VMS and were further limited by the high socioeconomic status of the racially homogenous sample.
In the current study, we sought to replicate the commonly found association between negative affect and VMS in a large multiethnic sample, using daily measures of VMS and affect as opposed to annual retrospective measures. We also examined the directional relationship between VMS and negative affect on a day-to-day basis, determining whether VMS predicts next-day negative affect, and whether negative affect predicts next-day VMS.
METHODS

Participants
The 625 women in the present analysis were drawn from the Daily Hormone Study (DHS), a substudy of the Study of Women's Health across the Nation (SWAN). SWAN is a multiethnic community-based natural history cohort study of 3,302 women at seven sites across the United States who were followed annually as they approached and traversed menopause. The details of recruitment and enrollment have been reported elsewhere in detail. 19 Briefly, eligible women were, at baseline, aged 42 to 52 years, self-identified with one of five racial/ethnic groups (white, African American, Chinese, Japanese, or Hispanic), reported at least one menstrual period in the past 3 months, did not use sex-steroid hormones in the past 3 months, had an intact uterus and at least one ovary, and were not currently pregnant or breastfeeding. 20 The same eligibility criteria were used for the DHS. Of the women in the SWAN cohort, 1,443 were screened, 1,219 were eligible, and 848 (69.6%) agreed to participate and provided a sufficiently complete cycle at the first DHS year, with 651 participating at year 3 of the DHS. The reasons for discontinuation or nonparticipation in DHS year 3 included current or recent (within the previous 3 months) hormone therapy use (n = 65), fertility medication use (n = 1), oral contraceptive use (n = 3), bilateral oophorectomy (n = 7), more than 1 year of amenorrhea (n = 7; women were eligible in the first year of becoming postmenopausal), refusal or inability to participate in that year's DHS visit (n = 40), and attrition from SWAN (n = 74). Women who had a hysterectomy were eligible as long as they retained one or both ovaries. Year 3 of the DHS was chosen as the analytic sample because it is composed of a larger percentage of perimenopausal women (81.2%) relative to earlier years, the time in which participants are likely to report VMS. 1 Participants completed daily diaries over a period of 12 to 50 days (mean [SD], 33.91 [10.85] days) and were excluded from analysis if they were missing daily diary data on VMS and affect on all observations (n = 26). The 26 excluded women were more likely to be from the New Jersey site (P G 0.01), to be Hispanic (P G 0.01), to have a high school education or less (P G 0.01), to report fair/poor self-rated health (P = 0.02), and to have a higher body mass index (BMI; P = 0.02) than the 625 women in the final analytic sample (data not shown).
Procedure
DHS enrollees rated mood and physical symptoms that had occurred within the preceding 24 hours in diaries at the end of each day. The participants were instructed to complete these diaries daily for the duration of an entire menstrual cycle ending in bleeding or 50 days, whichever came first. Women who did not have a bleeding cycle coincident with a 1-year follow-up began on the next convenient day and collected for 50 days or until a menstrual cycle began. Women who had no menses for the 12 months before an annual follow-up kept a daily diary for 25 days. 20 The start date of the DHS was scheduled within 6 months of the SWAN core visit.
Measures
Diary measures of symptoms
The women rated how strongly they felt 14 mood and physical states (happy, bored, headaches, blue/down, tired, aches/pains, calm, forgetful, mood swings, irritable, anxious, confident/in control, difficulty concentrating, and feelings easily hurt) in the last 24 hours using a 4-point scale ranging from Bnot at all[ (1) to Ba lot[ (4). They indicated whether hot flashes/night sweats, trouble sleeping, and abdominal pain/cramps (all yes/no) had occurred in the last 24 hours.
A principal components analysis with an oblique rotation in SPSS 21 on the 14 items of the daily diary yielded three factors. The first component was composed of seven items related to negative mood: mood swings, feelings easily hurt, irritable, difficulty concentrating, forgetful, anxious, and blue/down. This component explained 39.0% of the variance and had a Cronbach > of 0.87. The mean of these seven items each day for each participant was used to create daily and overall mean composite negative mood variables., These scores were dichotomized for analysis because of their significantly skewed distribution, with scores of 2 or greater indicating the presence of negative mood. Two was chosen as the cutoff because it represented a meaningful value on the Likert scale, dividing endorsing symptoms Bnot at all[ to Ba little bit[ or more. The second component was composed of three items related to positive mood: confident/in control, happy, and calm. This factor explained 10.2% of the variance and had a Cronbach > of 0.77. Daily and overall mean composite positive mood variables were created from the ratings of these three items for each participant and were treated as continuous variables. The third factor was composed of three items related to somatic symptoms: headaches, tiredness, and aches/pains. This factor explained 8.0% of the variance and had a Cronbach > of 0.64. This factor was not considered in this analysis.
Covariates
Potential covariates were selected because of their associations with VMS and negative mood in the literature. The covariates considered were site, age, education, and race (white, African American, Chinese, Hispanic, or Japanese), drawn from baseline, and physical activity, self-rated health, BMI, smoking, menopause status, and antidepressant use, assessed anually and drawn for this analysis from the annual SWAN visit preceding and most proximal to DHS data collection. Education was determined using one question that asks the highest grade completed or degree attained 22 and was coded as high school or less, some college, and completed college or postcollege. Physical activity was assessed using the Kaiser Physical Activity Survey, 23 an adaptation of the Baecke physical activity questionnaire. 24 Self-rated health was assessed by response to the following question: BIn general, would you say your health is excellent, very good, good, fair, or poor?[ The responses were grouped into four categories, with the responses of Bfair[ and Bpoor[ collapsed into a single category. BMI was calculated using weight (in kilograms) and the square of height (in meters) and was categorized (underweight/normal: G25 kg/m 2 ; overweight: 25-30 kg/m 2 ; obese: 930 kg/m 2 ). Smoking status (never, ever, or current) was self-reported at each visit. Menopause status was assessed annually in SWAN and was defined as indeterminant (premenopausal and perimenopausal women who used hormones in the past year), premenopausal (bleeding in the last 3 mo with no cycle irregularity in the previous 12 mo), early perimenopausal (bleeding in the last 3 mo with some change in cycle regularity in the last 12 mo), late perimenopausal (bleeding 93 mo ago but within the last 12 mo), and postmenopausal (no bleeding in the last 12 mo). Menopause status was collapsed into three categories: premenopausal, perimenopausal (early and late perimenopausal), and postmenopausal. For this analysis, the records were reviewed to reclassify the women defined as indeterminant as premenopausal (n = 1) or perimenopausal (n = 9), based on their status at annual visits before and after the annual visit coinciding with their DHS data collection. Current antidepressant use was self-reported in response to questions about medications used currently and in the previous year during each annual SWAN visit.
Analytic plan
We assessed the differences between the women who reported ever having vasomotor symptoms during the observed time period and those who did not using logistic regression. We assessed the associations between potential covariates and overall positive mood with linear regression. Descriptive analysis was conducted to evaluate the overall proportions of days that the women experienced mood and VMS over the observed period.
We examined daily observations, nested within women, using two-level hierarchical generalized linear models. To examine daily associations between negative affect and VMS, daily negative affect was regressed on same-day VMS; in separate models, daily VMS was regressed on same-day negative affect. To examine the day-to-day temporal associations between affect and VMS, we used lagged analysis. Specifically, negative affect at time t, adjusted by vasomotor symptoms at time t, was examined as a predictor of vasomotor symptoms at time t + 1; vasomotor symptoms at time t, adjusted by negative affect at time t, was examined as a predictor of negative affect at time t + 1. The daily-level intercept was regressed on woman-level covariates. A similar approach was used to evaluate the association between positive mood and VMS. Race/ethnicity, menopause status, self-rated health, age, and education were included as covariates in final models with VMS or positive affect as the outcome; race/ethnicity, menopause status, self-rated health, and antideprssant use were included as covariates in final models with negative affect as the outcome. We used SPSS version 17 21 to conduct univariate analyses of overall associations and HLM 6.08 25 to run the hierarchical generalized models of daily associations between affect and VMS.
RESULTS
Characteristics of sample
Participants represented the racial/ethnic diversity of SWAN (30.6% white, 22.9% Japanese, 19.7% African American, 19.5% Chinese, 7.4% Hispanic) and were largely perimenopausal (81.6%) and well educated (44.8% with a college or professional degree), with an average age of 48.8 years at the time of data collection. During the observed period, 52.3% of participants (n = 327) ever reported VMS (Table 1) . Ever reporting VMS varied by race, age, menopause status, selfrated health, and site and was associated with a higher mean negative mood and a lower mean positive mood during the course of the daily diary collection ( Table 1 ). The odds of reporting daily VMS were also increased among women with less education. Most of the variance (95%) in daily VMS reporting was seen between women, with 5% of the variance occurring within women's daily observations.
In univariate models, the odds of reporting daily negative mood were lower among older women and African American (compared with white) women and were higher among perimenopausal (compared with premenopausal) women and among women reporting antidepressant use and poorer self-rated health (data not shown). Most of the variance (96%) in daily negative mood reporting was seen between women, with 4% of the variance occurring within women's daily observations. The odds of reporting daily positive mood were increased among women with more education and in younger and African American (compared with white) women and were lower among perimenopausal (compared with premenopausal) women and among women reporting poor self-rated health. Most of the variance (64%) in positive mood reporting was seen between women, with 36% of the variance occurring within women's daily observations.
Daily covariance of VMS and negative affect
VMS and negative affect were significantly associated with each other within each 24-hour period ( Table 2 ). Older age, poorer health, and perimenopause status (compared with premenopause status) increased the likelihood of reporting VMS on a given day, whereas being Chinese was associated with reduced odds of daily VMS ( Table 2) . Similar results were found when daily negative affect was set as the outcome and VMS was the predictor (data not shown). 
Negative affect as a predictor of next-day VMS
Negative mood, adjusted by same-day VMS, was not associated with next-day VMS. In the fully adjusted model, previous-day VMS, older age, poor health, and perimenopause status was associated with increased odds of reporting next-day VMS; being Chinese was negatively associated with next-day VMS ( Table 3) .
VMS as a predictor of next-day negative affect
VMS, adjusted by same-day negative affect, was significantly associated with next-day negative affect in unadjusted and adjusted models. In the fully adjusted model, previous-day VMS, previous-day negative mood, antidepressant use, poorer health, and perimenopause status were each associated with increased odds of reporting negative mood the next day. Older women and African American women were less likely to report next-day negative mood (Table 4 ).
Secondary analyses
Negative mood was replaced with positive mood in a secondary analysis. VMS and positive affect were negatively associated with each other within each 24-hour period. No relationship was seen between positive affect and next-day VMS or between VMS and next-day positive affect (data not shown).
Race/ethnicity and BMI were explored as potential moderators of the relationship between daily VMS and negative affect, between VMS and next-day negative affect, and between negative affect and next-day VMS. No significant crosslevel interactions were found, indicating that race/ethnicity and BMI do not moderate these relationships (data not shown).
Because poor sleep is associated with negative mood, and self-reported sleep disruption is often attributed to night sweats, 16 sleep difficulty was explored as a potential factor that might account for the association between self-reported VMS and next-day negative affect. After adjustment for race/ ethnicity, menopause status, age, antidepressant use, and VMS within the same 24-hour period, reported trouble sleeping was significantly associated with next-day negative mood (OR = 1.97; 95% CI, 1.64-2.38; P G 0.001). The addition of trouble sleeping to the model reduced the significant relationship between previous-day VMS and next-day negative mood from OR = 1.27 (95% CI, 1.03-1.58; P G 0.001; Table 4 ), to a trend, OR = 1.24 (95% CI, 0.99-1.56; P = 0.06; data not shown).
DISCUSSION
It has been well established that the measures of negative affect and VMS are associated in women during the menopausal transition. However, methodological limitations of traditional symptom measurement have limited our ability to interpret this relationship. This study used prospective daily diary reports of mood and VMS to expand our current understanding of the commonly found relationship between these factors by examining both the daily and day-to-day associations between them. In this sample of women in midlife, higher average negative affect during the course of daily diary collection was associated with an increased risk of ever reporting VMS. On a day-to-day basis, higher negative affect was positively associated with VMS within each 24-hour period. This relationship was maintained regardless of whether negative affect or VMS was the predicted outcome. Our results suggest that the often-reported association between negative affect and VMS is present on a daily basis, even with the retrospective reporting bias limited by a short recall period.
The more novel aspect of the study was to determine the directionality of effect between negative affect and VMS. Negative affect was examined as a predictor of next-day VMS, whereas in separate models, VMS was considered as a predictor of next-day negative affect. In this sample, negative affect, adjusted by same-day VMS, was not associated with next-day VMS. In contrast, VMS, adjusted by same-day negative mood, was associated with next-day negative mood. Our finding is consistent with the notion that VMS may lead to negative mood over time via the activation of negative schemas about aging and the self and, perhaps, to chronic poor sleep attributable to disruptive night sweats. The inclusion of a rating of sleep quality in the daily diaries allowed us to examine the latter possibility. Adding sleep quality into the model reduced the association between VMS and next-day negative mood to a trend, but the amount of variance accounted for was small, with the OR reduced only by 0.03. Given the crude sleep measure, however, it is important that sleep is assessed with a more rigorous measure in future research. Other explanatory factors also remain to be explored. It is also possible that a third factor not assessed here may contribute to the risk of both negative mood symptoms and VMS. Estrogen withdrawal may have an impact on hypothalamic thermoregulatory centers as well as serotonergic, adrenergic, and noradrenergic systems, 5 which are systems that may play a role in VMS and mood.
These findings are partially consistent with those of Burleson et al, 18 who found that VMS preceded next-day negative mood in women, with sleep having a small but significant role in explaining this relationship. However, Burleson et al 18 saw this relationship only in women with low levels of depressive symptoms at baseline. They also found an association between VMS and decreased next-day positive affect, which was not replicated in this study. The ethnic diversity and low levels of negative mood generally reported in this sample may have contributed to the differences in findings.
Several commonly reported correlates of typical retrospectively measured VMS were also seen with the overall and daily reports of VMS in this prospective daily diary collection. As with past investigations, the risk of ever reporting VMS increased with age, 1 poorer health, 26 and perimenopause status. 1 The risk of reporting VMS on any given day was also associated with these factors, as well as with postmenopause status and lower educational attainment. These associations were consistent with past investigations of annually measured VMS 1, 27 and, with the exception of educational attainment, were maintained when entered into models simultaneously. Some factors commonly associated with VMS did not increase the risk of VMS reporting in this sample. Foremost among these were race/ethnicity and BMI. Although overall and daily VMS reporting varied significantly by race/ethnicity, this effect was driven by the reduced reporting seen only in Chinese women relative to other ethnic groups. Based on past assessments of VMS reporting by race, it was expected that VMS reporting would also be higher among African American women than among white women. 1 However, daily prospective reporting with decreased retrospective bias may better sample the true symptom experience of this population. In addition, BMI had no association with VMS in this sample, although increased BMI is related to an increased risk of VMS in numerous cross-sectional and longitudinal studies, including SWAN. 28 Some additional findings in this study deserve mention. Past studies using retrospectively self-reported VMS have indicated that VMS occur on a daily basis at some point in the menopausal transition for 20% to 25% of women. 10 The findings of this study suggest that most women who experience VMS do not have them daily; only 6.1% of symptomatic women reported VMS on every observation, whereas 56.7% of symptomatic women reported symptoms on just 2% to 30% of their daily observations. Prospective daily diary reporting may provide a more accurate representation of symptom frequency, with limited retrospective recall bias and error. The menopausal transition is also considered to be a vulnerable period for higher levels of depressive symptoms. 29 In this sample, prospective ratings of negative mood were very low, with most women reporting little to no endorsement of negative mood symptoms on a daily basis. In contrast, positive mood ratings were consistently relatively high, although these are more variable within women than negative mood ratings. This snapshot of the menopausal transition did not seem to represent a period of highly negative mood as measured with prospective daily reports in our large multiethnic, largely perimenopausal sample. However, it should be noted that women in the DHS had to be quite compliant and may represent a group with an overall more positive mood than the larger SWAN cohort that they were drawn from.
Several limitations of this study should be noted. As previously discussed, the time at which VMS occurred within the 24-hour interval was not determined. Whether the associations seen between mood and VMS were driven by hot flashes or night sweats therefore cannot be examined. Withinday frequency, severity, and bother of VMS were also not assessed, and these characteristics of VMS experience may play an important role in the relationship between daily VMS and daily mood. 3 Different relationships may have also been seen if physiologic VMS measures, rather than just selfreport, had been assessed. 7 The interpretation of these findings is also limited by the low levels and limited heterogeneity of daily negative mood reported in this sample, as the negative mood reported may not be of meaningful severity. Furthermore, 24-hour periods may not have been the appropriate time frame in which to see effects, particularly an association between negative affect and subsequent VMS. In Thurston et al, 7 self-reported VMS not confirmed by physiologically measured evidence of VMS occurrence was more probable within 30 minutes of negative emotional arousal. Negative affect may therefore have an acute impact on the perception and reporting of VMS, which would not have been captured during this extended period. Finally, participation in DHS is demanding; in addition to annual SWAN visits, these women complied with the annual completion of a month or more of daily diaries and daily urine collection. The generalizability of this highly compliant, highly motivated sample may be limited.
This study also has considerable strengths. Foremost among these is the contribution of the prospective daily measurement of mood and VMS, rather than the typical retrospective recall of symptom experience in previous weeks. This both confirms the stable relationship typically seen between these factors and elucidates the relationship between these transient and fluctuating factors on a day-to-day basis, adjusting by stable woman-level characteristics related to symptom experience. The size of the sample and the length of data collection lend validity, model stability, and the ability to examine over 21,000 separate observations. The multiethnic makeup of the sample provides valuable information about symptom experience in understudied populations. Finally, the large number of symptomatic women in this sample provided novel information about day-to-day symptom experience in a diverse sample of women in the menopausal transition.
CONCLUSIONS
This study contributes to our knowledge on the relationship between negative affect and VMS. The assessment of temporal relationships between negative affect and reported VMS suggests that VMS precedes elevated daily negative affect, whereas daily fluctuations in negative affect do not increase the likelihood of reported VMS. VMS may be affecting mood by way of sleep disturbance attributable to night sweats. Women with VMS may be at an increased risk of subsequent negative mood symptoms and sleep difficulty, which may have a broad impact on mood, health, and daily functioning. Healthcare practitioners should be aware of this potential detrimental effect of VMS experience in menopausal women and consider addressing VMS as an appropriate route to alleviating sleep difficulty and mood symptoms as well as VMS in the menopausal transition. This study takes us one step closer to better understanding of the relationship between negative mood and VMS, which may help inform intervention strategies to improve quality of life and health in women as and after they traverse menopause.
